Cargando…
Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused
Even several months after the start of a massive vaccination campaign against COVID-19, mortality and hospital admission are still high in many countries. Monoclonal antibodies against SARS-CoV-2 are the ideal complement to vaccination in infected subjects who are at high risk for progression to sev...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583134/ https://www.ncbi.nlm.nih.gov/pubmed/34769678 http://dx.doi.org/10.3390/ijerph182111159 |